> The U.S. Patent and Trademark Office has dropped regulations that sparked a lawsuit by GlaxoSmithKline and the two sides have asked a court to dismiss the suit. Report
> FDA declined Spectrum Pharmaceuticals' request to broaden use of its drug, Fusilev, to treat advanced metastatic colorectal cancer. Report
> Sanofi-Aventis and Merck KGaA are among international drugmakers expected to bid for iNova Pharmaceuticals, the Australian Financial Review said. Report
> More reason for older patients to get the herpes zoster vaccine: Researchers found that adults who get singles have a 30 percent greater risk of developing a stroke. Report
> Zantac 75, the GlaxoSmithKline-owned heartburn brand, is launching a press and radio campaign to drive awareness and differentiate it from competitor brands. Report
Biotech News:
> Amgen looks to boost its R&D success rate. Article
> Avanir unveils promising late-stage Zenvia data. Article
> FDA staffers question Acorda's MS drug. Article
> Quebec to make $123M biopharma investment Article
> Kansas spurs early-stage drug development with $50M in VC funding Article
And Finally... Swine flu drove a 15-fold increase in intensive care admissions for viral lung inflammation in Australia and New Zealand, a study found. Report